Professor Alan Emery | |
|---|---|
| Born | Alan Eglin Heathcote Emery 1928 (age 95–96) |
| Nationality | British |
| Occupation | Medical geneticist |
Alan Eglin Heathcote Emery FRCP, FRCPE, FLS, FRSA, FRSE (born 1928) is a British medical geneticist, known for his study of muscular dystrophy.
Emery began his working life in the King's Hussars,[1] and graduated in biological sciences from University of Manchester.[1] In 1960 he obtained his medical degree there.[1][2]
His PhD in human genetics was earned at Johns Hopkins University.[1][2]
In 1968 he became a foundation professor of human genetics at the University of Edinburgh.[1]
Having established the European Neuromuscular Centre, he was its chief scientific advisor from 1999.[1]
He was the first president of the Royal Society of Medicine’s Section of Medical Genetics, which he established, from 2001 to 2004.[1]
He was a research fellow and subsequently an honorary fellow of Green Templeton College from 1985.[1]
He was elected a Fellow of the Royal College of Physicians (FRCP), Fellow of the Royal College of Physicians of Edinburgh (FRCPE), a Fellow of the American College of Medical Genetics (FACMG), a Fellow of the Linnean Society (FLS), a Fellow of the Royal Society of Arts (FRSA) and a Fellow of the Royal Society of Edinburgh (FRSE).[1]
Both Emery–Dreifuss muscular dystrophy and its defective protein product, emerin, are named after him (the former jointly with Fritz E. Dreifuss)).[1]
References
- 1 2 3 4 5 6 7 8 9 10 Peter Harper; Lois Reynolds; Tilli Tansey, eds. (2010). Clinical Genetics in Britain: Origins and development. Wellcome Witnesses to Contemporary Medicine. History of Modern Biomedicine Research Group. ISBN 978-0-85484-127-1. Wikidata Q29581774.
- 1 2 "Alan Emery". University of Oxford. Retrieved 5 July 2017.
External links
- Alan Emery on the History of Modern Biomedicine Research Group website